Business ❯Companies ❯Pharmaceutical Companies

Novo Nordisk

Investment Investment and Expansion Market Value Amycretin CEO Lars Fruergaard Jørgensen Weight-loss Drug Market Acquisition Ozempic GLP-1s Financial Performance Sales Forecasts

Weight-Loss Drug Market Expands with New Generic Versions

OECD Slashes UK Growth Forecasts, Cites High Inflation Concerns

Diabetes Drug Lixisenatide Shows Promise in Slowing Parkinson's Progression

Novo Nordisk Acquires Cardior Pharmaceuticals for $1.1 Billion